-
1
-
-
33645513485
-
Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: Follow-up study
-
Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006 332 : 689 692.
-
(2006)
BMJ
, vol.332
, pp. 689-692
-
-
Zackrisson, S.1
Andersson, I.2
Janzon, L.3
Manjer, J.4
Garne, J.P.5
-
2
-
-
33645498004
-
Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmo trial
-
Zahl PH, Maehlen J. Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmo trial. BMJ 2006 332 : 727 728.
-
(2006)
BMJ
, vol.332
, pp. 727-728
-
-
Zahl, P.H.1
Maehlen, J.2
-
3
-
-
4344689012
-
Risk for distant recurrence of breast cancer detected by mammography screening or other methods
-
Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004 292 : 1064 1073.
-
(2004)
JAMA
, vol.292
, pp. 1064-1073
-
-
Joensuu, H.1
Lehtimaki, T.2
Holli, K.3
Elomaa, L.4
Turpeenniemi-Hujanen, T.5
Kataja, V.6
-
4
-
-
23844500059
-
Role of detection method in predicting breast cancer survival: Analysis of randomized screening trials
-
Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005 97 : 1195 1203.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1195-1203
-
-
Shen, Y.1
Yang, Y.2
Inoue, L.Y.3
Munsell, M.F.4
Miller, A.B.5
Berry, D.A.6
-
5
-
-
4344674096
-
Do tumors detected by mammography screening have a favorable prognosis?
-
O'Regan RM. Do tumors detected by mammography screening have a favorable prognosis? JAMA 2004 292 : 1062 1063.
-
(2004)
JAMA
, vol.292
, pp. 1062-1063
-
-
O'Regan, R.M.1
-
6
-
-
23844557872
-
Should screen-detected breast cancers be managed differently?
-
Krzyzanowska MK, Tannock IF. Should screen-detected breast cancers be managed differently? J Natl Cancer Inst 2005 97 : 1170 1171.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1170-1171
-
-
Krzyzanowska, M.K.1
Tannock, I.F.2
-
7
-
-
0033833676
-
The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: A review
-
Girdler F, Brotherick I. The oestrogen receptors (ER alpha and ER beta) and their role in breast cancer: a review. Breast 2000 9 : 194 200.
-
(2000)
Breast
, vol.9
, pp. 194-200
-
-
Girdler, F.1
Brotherick, I.2
-
8
-
-
0030579801
-
Cloning of a novel receptor expressed in rat prostate and ovary
-
Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996 93 : 5925 5930.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 5925-5930
-
-
Kuiper, G.G.1
Enmark, E.2
Pelto-Huikko, M.3
Nilsson, S.4
Gustafsson, J.A.5
-
9
-
-
4944246588
-
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression
-
Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004 11 : 537 551.
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 537-551
-
-
Bardin, A.1
Boulle, N.2
Lazennec, G.3
Vignon, F.4
Pujol, P.5
-
10
-
-
0037314762
-
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice
-
Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003 17 : 203 208.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 203-208
-
-
Lindberg, M.K.1
Moverare, S.2
Skrtic, S.3
Gao, H.4
Dahlman-Wright, K.5
Gustafsson, J.A.6
-
11
-
-
0035952371
-
Clinical value of the wild-type estrogen receptor beta expression in breast cancer
-
Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, et al. Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 2001 163 : 207 212.
-
(2001)
Cancer Lett
, vol.163
, pp. 207-212
-
-
Omoto, Y.1
Inoue, S.2
Ogawa, S.3
Toyama, T.4
Yamashita, H.5
Muramatsu, M.6
-
12
-
-
0036161026
-
Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers
-
Omoto Y, Kobayashi S, Inoue S, Ogawa S, Toyama T, Yamashita H, et al. Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancers. Eur J Cancer 2002 38 : 380 386.
-
(2002)
Eur J Cancer
, vol.38
, pp. 380-386
-
-
Omoto, Y.1
Kobayashi, S.2
Inoue, S.3
Ogawa, S.4
Toyama, T.5
Yamashita, H.6
-
13
-
-
2442553813
-
The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer
-
Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S, et al. The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer. J Clin Pathol 2004 57 : 523 528.
-
(2004)
J Clin Pathol
, vol.57
, pp. 523-528
-
-
Nakopoulou, L.1
Lazaris, A.C.2
Panayotopoulou, E.G.3
Giannopoulou, I.4
Givalos, N.5
Markaki, S.6
-
14
-
-
9144269004
-
Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer
-
Myers E, Fleming FJ, Crotty TB, Kelly G, McDermott EW, O'Higgins NJ, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine-resistant breast cancer. Br J Cancer 2004 91 : 1687 1693.
-
(2004)
Br J Cancer
, vol.91
, pp. 1687-1693
-
-
Myers, E.1
Fleming, F.J.2
Crotty, T.B.3
Kelly, G.4
McDermott, E.W.5
O'Higgins, N.J.6
-
15
-
-
0035122520
-
Estrogen receptor beta expression in invasive breast cancer
-
Mann S, Laucirica R, Carlson N, Younes PS, Ali N, Younes A, et al. Estrogen receptor beta expression in invasive breast cancer. Hum Pathol 2001 32 : 113 118.
-
(2001)
Hum Pathol
, vol.32
, pp. 113-118
-
-
Mann, S.1
Laucirica, R.2
Carlson, N.3
Younes, P.S.4
Ali, N.5
Younes, A.6
-
16
-
-
1342330354
-
Oestrogen receptor beta: What it means for patients with breast cancer
-
Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR, Hanby AM. Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncol 2004 5 : 174 181.
-
(2004)
Lancet Oncol
, vol.5
, pp. 174-181
-
-
Speirs, V.1
Carder, P.J.2
Lane, S.3
Dodwell, D.4
Lansdown, M.R.5
Hanby, A.M.6
-
17
-
-
0018614399
-
Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: Relation to oestradiol and progesterone cytosol receptors
-
Thorsen T. Occupied and unoccupied nuclear oestradiol receptor in human breast tumours: relation to oestradiol and progesterone cytosol receptors. J Steroid Biochem 1979 10 : 661 668.
-
(1979)
J Steroid Biochem
, vol.10
, pp. 661-668
-
-
Thorsen, T.1
-
18
-
-
0019970517
-
Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis
-
Maehle BO, Thoresen S, Skjaerven R, Hartveit F. Mean nuclear area and histological grade of axillary-node tumour in breast cancer, related to prognosis. Br J Cancer 1982 46 : 95 100.
-
(1982)
Br J Cancer
, vol.46
, pp. 95-100
-
-
Maehle, B.O.1
Thoresen, S.2
Skjaerven, R.3
Hartveit, F.4
-
19
-
-
0030659080
-
Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma
-
Straume O, Akslen LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997 74 : 535 539.
-
(1997)
Int J Cancer
, vol.74
, pp. 535-539
-
-
Straume, O.1
Akslen, L.A.2
-
20
-
-
2142760943
-
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer
-
Stefansson IM, Salvesen HB, Akslen LA. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol 2004 22 : 1242 1252.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1242-1252
-
-
Stefansson, I.M.1
Salvesen, H.B.2
Akslen, L.A.3
-
21
-
-
0030801841
-
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites
-
Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997 277 : 1508 1510.
-
(1997)
Science
, vol.277
, pp. 1508-1510
-
-
Paech, K.1
Webb, P.2
Kuiper, G.G.3
Nilsson, S.4
Gustafsson, J.5
Kushner, P.J.6
-
22
-
-
3242720708
-
Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: The Greek experience
-
Stefanou D, Batistatou A, Briasoulis E, Arkoumani E, Agnantis NJ. Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience. Eur J Gynaecol Oncol 2004 25 : 457 461.
-
(2004)
Eur J Gynaecol Oncol
, vol.25
, pp. 457-461
-
-
Stefanou, D.1
Batistatou, A.2
Briasoulis, E.3
Arkoumani, E.4
Agnantis, N.J.5
-
23
-
-
0038160964
-
Expression of estrogen receptor-beta in normal mammary and tumor tissues: Is it protective in breast carcinogenesis?
-
Park BW, Kim KS, Heo MK, Ko SS, Hong SW, Yang WI, et al. Expression of estrogen receptor-beta in normal mammary and tumor tissues: is it protective in breast carcinogenesis? Breast Cancer Res Treat 2003 80 : 79 85.
-
(2003)
Breast Cancer Res Treat
, vol.80
, pp. 79-85
-
-
Park, B.W.1
Kim, K.S.2
Heo, M.K.3
Ko, S.S.4
Hong, S.W.5
Yang, W.I.6
-
24
-
-
0038579655
-
Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation
-
Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 2003 39 : 1251 1258.
-
(2003)
Eur J Cancer
, vol.39
, pp. 1251-1258
-
-
Konstantinopoulos, P.A.1
Kominea, A.2
Vandoros, G.3
Sykiotis, G.P.4
Andricopoulos, P.5
Varakis, I.6
-
25
-
-
0032401855
-
Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis
-
Pujol P, Rey JM, Nirde P, Roger P, Gastaldi M, Laffargue F, et al. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res 1998 58 : 5367 5373.
-
(1998)
Cancer Res
, vol.58
, pp. 5367-5373
-
-
Pujol, P.1
Rey, J.M.2
Nirde, P.3
Roger, P.4
Gastaldi, M.5
Laffargue, F.6
-
26
-
-
0035878926
-
Frequent loss of estrogen receptor-beta expression in prostate cancer
-
Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001 61 : 5331 5335.
-
(2001)
Cancer Res
, vol.61
, pp. 5331-5335
-
-
Horvath, L.G.1
Henshall, S.M.2
Lee, C.S.3
Head, D.R.4
Quinn, D.I.5
Makela, S.6
-
27
-
-
0033231027
-
Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients
-
Speirs V, Malone C, Walton DS, Kerin MJ, Atkin SL. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res 1999 59 : 5421 5424.
-
(1999)
Cancer Res
, vol.59
, pp. 5421-5424
-
-
Speirs, V.1
Malone, C.2
Walton, D.S.3
Kerin, M.J.4
Atkin, S.L.5
-
28
-
-
33748305646
-
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours
-
Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer 2006 95 : 616 626.
-
(2006)
Br J Cancer
, vol.95
, pp. 616-626
-
-
Skliris, G.P.1
Leygue, E.2
Curtis-Snell, L.3
Watson, P.H.4
Murphy, L.C.5
-
29
-
-
18344363175
-
Estrogen receptor beta in breast cancer
-
DOI 10.1677/erc.0.0090001
-
Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Wärri A, Weihua Z, et al. Estrogen receptor beta in breast cancer. Endocr Relat Cancer 2002 9 : 1 13. (Pubitemid 34302928)
-
(2002)
Endocrine-Related Cancer
, vol.9
, Issue.1
, pp. 1-13
-
-
Palmieri, C.1
Cheng, G.J.2
Saji, S.3
Zelada-Hedman, M.4
Warri, A.5
Weihua, Z.6
Van Noorden, S.7
Wahlstrom, T.8
Coombes, R.C.9
Warner, M.10
Gustafsson, J.-A.11
-
30
-
-
34248159369
-
Lymph node status as a guide to selection of available prognostic markers in breast cancer: The clinical practice of the future?
-
Elzagheid A, Kuopio T, Pyrhonen S, Collan Y. Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future? Diagn Pathol 2006 1 : 41.
-
(2006)
Diagn Pathol
, vol.1
, pp. 41
-
-
Elzagheid, A.1
Kuopio, T.2
Pyrhonen, S.3
Collan, Y.4
-
31
-
-
1942542421
-
Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study
-
Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004 328 : 921 924.
-
(2004)
BMJ
, vol.328
, pp. 921-924
-
-
Zahl, P.H.1
Strand, B.H.2
Maehlen, J.3
|